Agilent Technologies operates in the healthcare sector, providing analytical instruments, software, services, and consumables for laboratories and research facilities. Its core products include life sciences and diagnostics solutions, as well as chemical analysis instruments. Major business segments encompass Life Sciences, Diagnostics, and Applied Markets, with primary revenue sources derived from product sales and service contracts.
The investment profile of Agilent Technologies is more aligned with value investors, given its moderate dividend yield and recent revenue decline. The stock may appeal to those seeking stability rather than aggressive growth. The current market conditions suggest a cautious approach for potential investors.
| Fecha | Antes | Después | Razón |
|---|---|---|---|
| 2026-05-30 02:56 | Vender | Mantener | Weak fundamentals offset recent price momentum. |
| 2026-05-16 02:39 | Mantener | Vender | Weak fundamentals and negative momentum indicate high risk. |
| 2026-05-08 15:10 | — | Mantener | Weak fundamentals and negative momentum raise concerns. |
| Fecha | Analista | Acción | Objetivo | Precio entonces |
|---|---|---|---|---|
| 2026-06-03 09:27 | HSBC | Objetivo reducido | 180 → 165 | 135.04 |
| 2026-05-28 12:35 | RBC Capital | Objetivo aumentado | 153 → 155 | 133.505 |
| 2026-05-28 10:48 | Robert W. Baird | Objetivo aumentado | 156 → 158 | 115.83 |
